ICU Medical Debt to Equity Ratio 2006-2019 | ICUI

Current and historical debt to equity ratio values for ICU Medical (ICUI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ICU Medical debt/equity for the three months ending March 31, 2019 was 0.00.
ICU Medical Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-03-31 $0.00B $1.28B 0.00
2018-12-31 $0.00B $1.26B 0.00
2018-09-30 $0.00B $1.26B 0.00
2018-06-30 $0.00B $1.26B 0.00
2018-03-31 $0.00B $1.23B 0.00
2017-12-31 $0.00B $1.20B 0.00
2017-09-30 $0.08B $1.14B 0.07
2017-06-30 $0.08B $1.12B 0.07
2017-03-31 $0.08B $1.14B 0.07
2016-12-31 $0.00B $0.66B 0.00
2016-09-30 $0.00B $0.65B 0.00
2016-06-30 $0.00B $0.62B 0.00
2016-03-31 $0.00B $0.60B 0.00
2015-12-31 $0.00B $0.58B 0.00
2015-09-30 $0.00B $0.57B 0.00
2015-06-30 $0.00B $0.54B 0.00
2015-03-31 $0.00B $0.52B 0.00
2014-12-31 $0.00B $0.51B 0.00
2014-09-30 $0.00B $0.49B 0.00
2014-06-30 $0.00B $0.49B 0.00
2014-03-31 $0.00B $0.47B 0.00
2013-12-31 $0.00B $0.47B 0.00
2013-09-30 $0.00B $0.43B 0.00
2013-06-30 $0.00B $0.42B 0.00
2013-03-31 $0.00B $0.40B 0.00
2012-12-31 $0.00B $0.39B 0.00
2012-09-30 $0.00B $0.37B 0.00
2012-06-30 $0.00B $0.35B 0.00
2012-03-31 $0.00B $0.34B 0.00
2011-12-31 $0.00B $0.32B 0.00
2011-09-30 $0.00B $0.31B 0.00
2011-06-30 $0.00B $0.31B 0.00
2011-03-31 $0.00B $0.29B 0.00
2010-12-31 $0.00B $0.27B 0.00
2010-09-30 $0.00B $0.26B 0.00
2010-06-30 $0.00B $0.25B 0.00
2010-03-31 $0.00B $0.25B 0.00
2009-12-31 $0.00B $0.27B 0.00
2009-09-30 $0.00B $0.28B 0.00
2009-06-30 $0.00B $0.27B 0.00
2009-03-31 $0.00B $0.26B 0.00
2008-12-31 $0.00B $0.25B 0.00
2008-09-30 $0.00B $0.24B 0.00
2008-06-30 $0.00B $0.23B 0.00
2008-03-31 $0.00B $0.22B 0.00
2007-12-31 $0.00B $0.21B 0.00
2007-09-30 $0.00B $0.22B 0.00
2007-06-30 $0.00B $0.23B 0.00
2007-03-31 $0.00B $0.23B 0.00
2006-12-31 $0.00B $0.23B 0.00
2006-09-30 $0.00B $0.22B 0.00
2006-06-30 $0.00B $0.21B 0.00
2006-03-31 $0.00B $0.20B 0.00
2005-12-31 $0.00B $0.19B 0.00
2005-09-30 $0.00B $0.18B 0.00
2005-06-30 $0.00B $0.17B 0.00
2005-03-31 $0.00B $0.16B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.983B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.051B 28.16
Medtronic (MDT) Ireland $130.762B 18.68
Stryker (SYK) United States $72.931B 26.03
Boston Scientific (BSX) United States $56.210B 26.95
Baxter (BAX) United States $39.757B 25.06
Zimmer Biomet Holdings (ZBH) United States $24.054B 15.45
Smith & Nephew SNATS (SNN) United Kingdom $18.710B 0.00
ResMed (RMD) United States $16.933B 32.35
Canopy Growth (CGC) Canada $14.186B 0.00
Bio-Rad Laboratories (BIO) United States $8.893B 47.15
Aurora Cannabis (ACB) Canada $7.667B 75.60
Hill-Rom Holdings (HRC) United States $6.972B 21.14
Insulet (PODD) United States $6.868B 500.39
Perrigo (PRGO) Ireland $5.872B 9.93
Haemonetics (HAE) United States $5.747B 46.91
GW Pharmaceuticals (GWPH) United Kingdom $5.154B 0.00
Hutchison China MediTech (HCM) China $3.506B 0.00
Neogen (NEOG) United States $3.232B 52.55
NuVasive (NUVA) United States $3.005B 24.54
Agios Pharmaceuticals (AGIO) United States $2.821B 0.00
National Vision Holdings (EYE) United States $2.350B 50.07
Quidel (QDEL) United States $2.233B 23.18
Aphria (APHA) $1.702B 0.00
Cardiovascular Systems (CSII) United States $1.388B 797.00
Phibro Animal Health (PAHC) United States $1.174B 17.58
AtriCure (ATRC) United States $1.144B 0.00
VAREX IMAGING (VREX) United States $1.089B 23.12
Lantheus Holdings (LNTH) United States $1.027B 27.27
OrganiGram Holdings (OGI) Canada $0.969B 0.00
NanoString Technologies (NSTG) United States $0.909B 0.00
PetIQ (PETQ) United States $0.837B 20.34
Quanterix (QTRX) United States $0.834B 0.00
Omeros (OMER) United States $0.795B 0.00
MacroGenics (MGNX) United States $0.743B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.724B 20.31
TG Therapeutics (TGTX) United States $0.639B 0.00
Cerus (CERS) United States $0.629B 0.00
Surmodics (SRDX) United States $0.558B 81.06
OraSure Technologies (OSUR) United States $0.530B 24.40
LeMaitre Vascular (LMAT) United States $0.513B 24.82
Meridian Bioscience (VIVO) United States $0.497B 15.18
Evolus (EOLS) United States $0.377B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.348B 0.00
Vapotherm (VAPO) United States $0.339B 0.00
BioLife Solutions (BLFS) United States $0.333B 104.06
Utah Medical Products (UTMD) United States $0.300B 20.78
Zynex (ZYXI) United States $0.282B 29.17
Rockwell Medical (RMTI) United States $0.241B 0.00
Bovie Medical (APYX) United States $0.213B 0.00
Cytosorbents (CTSO) United States $0.195B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Owens & Minor (OMI) United States $0.177B 3.75
Fonar (FONR) United States $0.135B 7.09
Female Health (VERU) United States $0.127B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
BRAINSWAY LTD (BWAY) Israel $0.094B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
United-Guardian (UG) United States $0.087B 19.15
Neurotrope (NTRP) United States $0.080B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.044B 15.21
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Senestech (SNES) United States $0.034B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.026B 0.00
Insys Therapeutics (INSY) United States $0.025B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.016B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.82